Cargando…
Inhibition of Influenza A Virus Infection In Vitro by Peptides Designed In Silico
Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causing severe human respiratory infections. Currently, only two types of drugs are used to treat influenza A infections, the M2 H(+) ion channel blockers (amantadine and rimantadine) and the neuraminidase...
Autores principales: | López-Martínez, Rogelio, Ramírez-Salinas, G. Lizbeth, Correa-Basurto, José, Barrón, Blanca L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795628/ https://www.ncbi.nlm.nih.gov/pubmed/24146939 http://dx.doi.org/10.1371/journal.pone.0076876 |
Ejemplares similares
-
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020) -
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
por: Ramírez Salinas, Gema Lizbeth, et al.
Publicado: (2023) -
The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitro
por: Reyes-Barrera, Karen Lizbeth, et al.
Publicado: (2021) -
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
por: García-Machorro, Jazmín, et al.
Publicado: (2022) -
Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies
por: Ramírez-Salinas, G. Lizbeth, et al.
Publicado: (2020)